CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Company

Emergent BioSolutions Inc.

Filed

February 9, 2024

Accession Number

0001085146-24-001015

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →